Trial Profile
Combined Use of Intranasal Oxytocin and Interpersonal Psychotherapy for the Treatment of Major Depressive Disorder (MDD): A Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms TOAD2015
- 21 Jul 2021 Status changed from recruiting to completed.
- 07 Apr 2015 New trial record